The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: A retrospective analysis of the FEATHER study-Reference-Cited by-同舟云学术

The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: A retrospective analysis of the FEATHER study

Published:2014-09 Issue:3 Volume:134 Page:552-557
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Jakubowski Joseph A.,Angiolillo Dominick J.,Zhou Chunmei,Small David S.,Moser Brian A.,ten Berg Jurrien M.,Brown Patricia B.,James Stefan,Winters Kenneth J.,Erlinge David

Publisher

Elsevier BV

Subject

Hematology

Reference31 articles.

1. Platelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading-dose be weight adjusted?;Angiolillo;J Invasive Cardiol,2004

2. Impact of body mass index on platelet aggregation after administration of a high loading dose of 600mg of clopidogrel before percutaneous coronary intervention;Sibbing;Am J Cardiol,2007

3. Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel;Ang;J Am Coll Cardiol,2008

4. Clopidogrel resistance: role of body mass and concomitant medications;Feher;Int J Cardiol,2007

5. Obesity is associated with poor response to clopidogrel and an increased susceptibility to protease activated receptor-1 mediated platelet activation;Gremmel;Transl Res,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiplatelet Effect of Low-Dose Prasugrel in Elderly Patients Undergoing Percutaneous Coronary Interventions;Current Vascular Pharmacology;2024-09

2. Impact of body mass index on efficacy and safety of ticagrelor versus clopidogrel in patients with minor stroke or transient ischemic attack;Canadian Medical Association Journal;2023-07-09

3. Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes—a substudy of the TROPICAL-ACS trial;European Heart Journal - Cardiovascular Pharmacotherapy;2023-04-04

4. Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes;Vascular Pharmacology;2023-04

5. Precision antiplatelet therapy;Research and Practice in Thrombosis and Haemostasis;2023-03